loading
Precedente Chiudi:
$1.41
Aprire:
$1.398
Volume 24 ore:
9.29M
Relative Volume:
2.26
Capitalizzazione di mercato:
$132.30M
Reddito:
-
Utile/perdita netta:
$-117.23M
Rapporto P/E:
-0.7489
EPS:
-2.23
Flusso di cassa netto:
$-95.25M
1 W Prestazione:
-39.27%
1M Prestazione:
-24.77%
6M Prestazione:
-47.65%
1 anno Prestazione:
-33.73%
Intervallo 1D:
Value
$1.35
$1.67
Intervallo di 1 settimana:
Value
$0.9867
$2.92
Portata 52W:
Value
$0.9867
$7.01

Tenaya Therapeutics Inc Stock (TNYA) Company Profile

Name
Nome
Tenaya Therapeutics Inc
Name
Telefono
415-865-2066
Name
Indirizzo
171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO
Name
Dipendente
140
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
TNYA's Discussions on Twitter

Confronta TNYA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
TNYA
Tenaya Therapeutics Inc
1.67 132.30M 0 -117.23M -95.25M -1.44
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
397.27 102.31B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
701.85 77.13B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
623.82 37.30B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
245.44 31.66B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
113.08 27.11B 3.30B -501.07M 1.03B -2.1146

Tenaya Therapeutics Inc Stock (TNYA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-06-10 Iniziato William Blair Outperform
2023-11-30 Iniziato Leerink Partners Outperform
2022-06-15 Iniziato H.C. Wainwright Buy

Tenaya Therapeutics Inc Borsa (TNYA) Ultime notizie

pulisher
Dec 20, 2024

Tenaya Therapeutics (NASDAQ:TNYA) Earns Buy Rating from Chardan Capital - Defense World

Dec 20, 2024
pulisher
Dec 20, 2024

Tenaya Therapeutics (NASDAQ:TNYA) Earns “Buy” Rating from HC Wainwright - Defense World

Dec 20, 2024
pulisher
Dec 19, 2024

Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives $17.33 Average PT from Brokerages - MarketBeat

Dec 19, 2024
pulisher
Dec 19, 2024

Tenaya Therapeutics (NASDAQ: TNYA) Senior Vice President Chihiro Saito Resigns: 8-K Filing - Defense World

Dec 19, 2024
pulisher
Dec 18, 2024

Tenaya Therapeutics stock backed by H.C. Wainwright on TN-401 safety and protein expression gains - Investing.com

Dec 18, 2024
pulisher
Dec 18, 2024

Tenaya Therapeutics (NASDAQ:TNYA) Receives "Buy" Rating from Chardan Capital - MarketBeat

Dec 18, 2024
pulisher
Dec 18, 2024

Tenaya Therapeutics (NASDAQ:TNYA) Given "Buy" Rating at HC Wainwright - MarketBeat

Dec 18, 2024
pulisher
Dec 18, 2024

Tenaya Stock Crashes as Cardio Gene Therapy Delivers Underwhelming Early-Stage Data - BioSpace

Dec 18, 2024
pulisher
Dec 18, 2024

Contrasting Tenaya Therapeutics (NASDAQ:TNYA) and Vaxart (NASDAQ:VXRT) - Defense World

Dec 18, 2024
pulisher
Dec 18, 2024

Tenaya Therapeutics stock hits 52-week low at $1.49 By Investing.com - Investing.com Canada

Dec 18, 2024
pulisher
Dec 17, 2024

Tenaya stock in selloff on gene therapy data (TNYA:NASDAQ) - Seeking Alpha

Dec 17, 2024
pulisher
Dec 17, 2024

Tenaya Therapeutics announces executive departure - Investing.com

Dec 17, 2024
pulisher
Dec 17, 2024

Tenaya Therapeutics stock hits 52-week low at $1.49 - Investing.com

Dec 17, 2024
pulisher
Dec 17, 2024

Tenaya Therapeutics Reports Promising TN-201 Trial Results - TipRanks

Dec 17, 2024
pulisher
Dec 17, 2024

Tenaya Therapeutics’ Senior VP Resigns for New Opportunity - TipRanks

Dec 17, 2024
pulisher
Dec 17, 2024

Tenaya reports positive early data on heart gene therapy - Investing.com

Dec 17, 2024
pulisher
Dec 17, 2024

Tenaya Therapeutics Reports Promising Early Data from MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 for Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy - GlobeNewswire

Dec 17, 2024
pulisher
Dec 16, 2024

Tenaya Therapeutics to Announce Initial Data from MyPEAK-1 Phase 1b/2 Clinical Trial of TN-201 Gene Therapy for MYBPC3-Associated Hypertrophic Cardiomyopathy on Tuesday, December 17, 2024 - The Manila Times

Dec 16, 2024
pulisher
Dec 16, 2024

Tenaya Therapeutics to Unveil Groundbreaking Gene Therapy Data for Heart Disease Treatment - StockTitan

Dec 16, 2024
pulisher
Dec 16, 2024

Tenaya Therapeutics to Announce Initial Data from MyPEAK-1 - GlobeNewswire

Dec 16, 2024
pulisher
Dec 15, 2024

Fmr LLC Raises Stock Holdings in Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World

Dec 15, 2024
pulisher
Dec 10, 2024

Tenaya Therapeutics' SWOT analysis: gene therapy stock faces pivotal catalysts - Investing.com

Dec 10, 2024
pulisher
Dec 10, 2024

Jacobs Levy Equity Management Inc. Buys 226,466 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - MarketBeat

Dec 10, 2024
pulisher
Dec 05, 2024

Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Stake Decreased by RA Capital Management L.P. - MarketBeat

Dec 05, 2024
pulisher
Nov 28, 2024

Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Short Interest Update - MarketBeat

Nov 28, 2024
pulisher
Nov 27, 2024

Around the Helix: Cell and Gene Therapy Company Updates – November 27, 2024 - CGTLive™

Nov 27, 2024
pulisher
Nov 26, 2024

First Patient Dosed in RIDGE-1 Trial for Tenaya’s ARV Cardiomyopathy Gene Therapy TN-401 - CGTLive™

Nov 26, 2024
pulisher
Nov 26, 2024

Tenaya shares retain Buy rating, price target on trial update - Investing.com

Nov 26, 2024
pulisher
Nov 25, 2024

Tenaya Therapeutics Doses First Patient in RIDGE™-1 Phase - GlobeNewswire

Nov 25, 2024
pulisher
Nov 25, 2024

Tenaya Therapeutics Launches First-Ever PKP2-ARVC Gene Therapy Trial, Doses Initial Patient | TNYA Stock News - StockTitan

Nov 25, 2024
pulisher
Nov 24, 2024

Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives $14.75 Average Target Price from Brokerages - MarketBeat

Nov 24, 2024
pulisher
Nov 21, 2024

Tenaya Therapeutics Reports Q3 2024 Progress and Financial Results - TipRanks

Nov 21, 2024
pulisher
Nov 19, 2024

Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - The Manila Times

Nov 19, 2024
pulisher
Nov 19, 2024

Tenaya Therapeutics Issues Stock Options to New Employees at $1.97 Per Share | TNYA Stock News - StockTitan

Nov 19, 2024
pulisher
Nov 18, 2024

Tenaya Therapeutics SVP sells $4,786 in stock By Investing.com - Investing.com UK

Nov 18, 2024
pulisher
Nov 18, 2024

Tenaya Therapeutics SVP sells $4,786 in stock - Investing.com

Nov 18, 2024
pulisher
Nov 15, 2024

RA Capital Management's Strategic Acquisition in Tenaya Therapeu - GuruFocus.com

Nov 15, 2024
pulisher
Nov 11, 2024

Research Analysts Offer Predictions for TNYA FY2024 Earnings - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

Leerink Partnrs Issues Optimistic Estimate for TNYA Earnings - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

William Blair Brokers Increase Earnings Estimates for TNYA - MarketBeat

Nov 11, 2024
pulisher
Nov 10, 2024

Tenaya Therapeutics, Inc.'s (NASDAQ:TNYA) large institutional owners must be happy as stock continues to impress, up 42% over the past week - Simply Wall St

Nov 10, 2024
pulisher
Nov 07, 2024

Tenaya Therapeutics (NASDAQ:TNYA) Price Target Lowered to $18.00 at Chardan Capital - MarketBeat

Nov 07, 2024
pulisher
Nov 06, 2024

Latham Group, Inc. to Participate in the Baird 2024 Global Industrial Conference - The Manila Times

Nov 06, 2024
pulisher
Nov 06, 2024

Tenaya Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire

Nov 06, 2024
pulisher
Nov 05, 2024

abrdn plc Invests $1.06 Million in Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - MarketBeat

Nov 05, 2024
pulisher
Nov 04, 2024

BeyondSpring (BYSI) Stock Drops Amid Biotech Sector Volatility - GuruFocus.com

Nov 04, 2024
pulisher
Nov 04, 2024

Beam Therapeutics (BEAM) Stock Surges with Strong Trading Volume - GuruFocus.com

Nov 04, 2024
pulisher
Nov 03, 2024

Morgan Stanley Predicts Up to 670% Jump for These 2 ‘Strong Buy’ Stocks - Yahoo Finance

Nov 03, 2024
pulisher
Nov 01, 2024

Here's Why We're Watching Tenaya Therapeutics' (NASDAQ:TNYA) Cash Burn Situation - Yahoo Finance

Nov 01, 2024
pulisher
Oct 31, 2024

Layoff Tracker: Compass Pathways to Lay Off 30% of Employees - BioSpace

Oct 31, 2024
pulisher
Oct 30, 2024

Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Given Consensus Rating of "Buy" by Analysts - MarketBeat

Oct 30, 2024

Tenaya Therapeutics Inc Azioni (TNYA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Tenaya Therapeutics Inc Azioni (TNYA) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Saito Chihiro
SVP, Accounting and Fin. Ops.
Aug 16 '24
Sale
2.89
2,363
6,840
63,241
Tingley Whittemore
Chief Medical Officer
Aug 16 '24
Sale
2.89
7,428
21,500
107,106
Ali Faraz
Chief Executive Officer
Aug 16 '24
Sale
2.89
9,748
28,216
188,331
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
Capitalizzazione:     |  Volume (24 ore):